In vitro methods for studying the mechanisms of resistance to DNA-damaging therapeutic drugs

File Description SizeFormat 
Final draft_book chapter 20250614_Ver.1_AM_Ref Edt[1].docxAccepted version92.63 kBMicrosoft WordView/Open
Title: In vitro methods for studying the mechanisms of resistance to DNA-damaging therapeutic drugs
Authors: Khongkow, P
Middleton, AK
Wong, JP
Kandola, NK
Kongsema, M
De Moraes, GN
Gomes, AR
Lam, EW
Item Type: Journal Article
Abstract: Most commonly used anticancer drugs exert their effects mainly by causing DNA damage. The enhancement in DNA damage response (DDR) is considered a key mechanism that enables cancer cells to survive through eliminating the damaged DNA lesions and thereby developing resistance to DNA-damaging agents. This chapter describes the four experimental approaches for studying DDR and genotoxic drug resistance, including the use of γ-H2AX and comet assays to monitor DNA damage and repair capacity as well as the use of clonogenic and β-galactosidase staining assays to assess long-term cell fate after DNA-damaging treatment. Finally, we also present examples of these methods currently used in our laboratory for studying the role of FOXM1 in DNA damage-induced senescence and epirubicin resistance.
Issue Date: 25-Feb-2016
Date of Acceptance: 25-Feb-2016
URI: http://hdl.handle.net/10044/1/39194
DOI: https://dx.doi.org/10.1007/978-1-4939-3347-1_3
ISSN: 1940-6029
Publisher: Springer Verlag
Start Page: 39
End Page: 53
Journal / Book Title: Methods in Molecular Biology
Volume: 1395
Copyright Statement: The final publication is available at Springer via http://dx.doi.org/10.1007/978-1-4939-3347-1_3
Sponsor/Funder: Royal Thai Embassy
Royal Thai Embassy
Funder's Grant Number: WSCC_P37917
WSCC_P39496
Keywords: Clonogenic assay
Comet assay
DNA damage
Resistance
β-Galactosidase staining
γ-H2AX
Developmental Biology
0601 Biochemistry And Cell Biology
Publication Status: Published
Appears in Collections:Division of Surgery
Division of Cancer
Faculty of Medicine



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commons